The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...

As October draws to a close, it's time to take a look at the regulatory news that made headlines in the month and look ahead to ...

Glucocorticoid tapering: Weekly mean glucocorticoid doses were reduced by 70.1% after 2 weeks of treatment. By week 8, glucocorticoids were tapered to a clinically meaningful dose of ≤1 mg/kg/day in ...

Cabozantinib is the active ingredient in two of Exelixis' three approved drugs (Cabometyx and Cometriq) and its strongest US patent covering cabozantinib’s composition of matter expires in 2030.

Deputy Industry Minister Faisol Reza has issued a warning to skincare producers who engage in overclaiming practices.

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs).

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic ...

You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

The spider web tarts were sold last weekend at farmers markets in Maryland, Virginia and the District of Columbia.

Learn about the best time of day and way to take vitamin D and if you should consider a supplementing with this nutrient.